Advanced Wound/Burn Formulation
Major Wounds and Burns
Pre-clinicalActive
Key Facts
About Pagari Life Science
Pagari Life Science is an early-stage biotech developing a proprietary platform for anti-herpetic and wound healing drugs. The company has already commercialized its first product, Helocaine, for over-the-counter treatment of cold sores and minor skin injuries. Its pipeline includes preclinical programs for genital herpes and shingles, developed in partnership with the NIH/NIAID, targeting significant unmet needs in pain management and viral resolution. Pagari operates as a private, likely pre-revenue entity leveraging external research collaborations to advance its core technology.
View full company profile